The Seroprevalence of SARS-CoV-2 Antibody in the Asymptomatic Population

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Not a clinical trial

Funding Statement

Institutional Self-funded

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Western IRB reviewed the study under the Common Rule and applicable guidance and determined it is exempt under 45 CFR 46.104(d)(4) using de-identified study samples for epidemiologic investigation.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes